Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 6518
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135819(US10085990, Example 103 | US10568888, Example 103 ...)
Affinity DataIC50:  17nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135824(US10085990, Example 127 | US10568888, Example 127 ...)
Affinity DataIC50:  25nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135822(US10085990, Example 121 | US10568888, Example 121 ...)
Affinity DataIC50:  26nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135823(US10085990, Example 122 | US10568888, Example 122 ...)
Affinity DataIC50:  39nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135820(US10085990, Example 115 | US10568888, Example 115 ...)
Affinity DataIC50:  49nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135819(US10085990, Example 103 | US10568888, Example 103 ...)
Affinity DataIC50:  55nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135822(US10085990, Example 121 | US10568888, Example 121 ...)
Affinity DataIC50:  59nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135818(US10085990, Example 92 | US10568888, Example 92 | ...)
Affinity DataIC50:  68nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135824(US10085990, Example 127 | US10568888, Example 127 ...)
Affinity DataIC50:  73nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135816(US10085990, Example 54 | US10568888, Example 54 | ...)
Affinity DataIC50:  78nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135821(US10085990, Example 118 | US10568888, Example 118 ...)
Affinity DataIC50:  80nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135823(US10085990, Example 122 | US10568888, Example 122 ...)
Affinity DataIC50:  80nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135815(US10085990, Example 51 | US10568888, Example 51 | ...)
Affinity DataIC50:  126nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135818(US10085990, Example 92 | US10568888, Example 92 | ...)
Affinity DataIC50:  151nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135820(US10085990, Example 115 | US10568888, Example 115 ...)
Affinity DataIC50:  163nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135821(US10085990, Example 118 | US10568888, Example 118 ...)
Affinity DataIC50:  206nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135816(US10085990, Example 54 | US10568888, Example 54 | ...)
Affinity DataIC50:  338nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135817(US10085990, Example 84 | US10568888, Example 84 | ...)
Affinity DataIC50:  513nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135815(US10085990, Example 51 | US10568888, Example 51 | ...)
Affinity DataIC50:  616nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135817(US10085990, Example 84 | US10568888, Example 84 | ...)
Affinity DataIC50:  827nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135814(US10085990, Example 33 | US10568888, Example 33 | ...)
Affinity DataIC50:  1.24E+4nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135812(US10085990, Example 30 | US10568888, Example 30 | ...)
Affinity DataIC50:  1.70E+4nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135813(US10085990, Example 32 | US10568888, Example 32 | ...)
Affinity DataIC50:  2.50E+4nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135812(US10085990, Example 30 | US10568888, Example 30 | ...)
Affinity DataIC50:  2.50E+4nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135813(US10085990, Example 32 | US10568888, Example 32 | ...)
Affinity DataIC50:  2.50E+4nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
High Point Pharmaceuticals

US Patent
LigandPNGBDBM135814(US10085990, Example 33 | US10568888, Example 33 | ...)
Affinity DataIC50:  2.50E+4nMAssay Description:A TR-FRET-based phosphodiesterase assay kit from "Molecular Devices" was used to test whether these compounds were indeed direct inhibitors of the PD...More data for this Ligand-Target Pair
In DepthDetails US Patent